HealthcareResearch sheds light on crimean-congo hemorrhagic fever disease process

Research sheds light on crimean-congo hemorrhagic fever disease process

Research sheds light on crimean-congo hemorrhagic fever disease process
Crimean-Congo hemorrhagic fever virus causes a catastrophic destruction of Kupffer cells in mice lacking type I interferon signaling, as indicated by a nearly complete loss of the Kupffer cell surface marker CLEC4F. In contrast, this image shows that the CLEC4F-positive Kupffer cells (red) are not lost during infection in mice lacking mitochondrial antiviral signaling protein where type I interferon activity was also blocked by antibody. Additionally, viral protein (green) was only detected in the CLEC4F-positive Kupffer cells (red). Cell nuclei were stained in fluorescent blue. These data demonstrate that Crimean-Congo hemorrhagic fever virus liver injury in MAVS-deficient mice is much more limited compared to infection in non-transgenic wild-type mice. Credit: Jeffrey M. Smith, USAMRIID

Army scientists determined that the body’s own natural immune response contributes to disease severity in mice infected with Crimean-Congo hemorrhagic fever virus (CCHFV), which causes a widespread tick-borne viral infection in humans. Their work, published May 19, 2022 in PLoS Pathogens, provides a deeper understanding of how the virus causes disease and forms a basis for developing medical countermeasures to prevent and treat infection.

CCHFV is endemic in Asia, Africa and Eastern Europe, and recent outbreaks have occurred in Western Europe. For these reasons, it is considered a priority pathogen by the World Health Organization. There are currently no or vaccines against CCHFV, which causes disease ranging from minimally symptomatic to catastrophic and lethal. While it is unclear why some patients develop mild illness and others succumb to the disease, suggest that the host —a complex reaction of the body that is triggered when healthy tissues are invaded by the —may be an important factor in mediating disease outcome. Until now, however, the importance of the host response in driving the disease process has not been shown experimentally.

To investigate this avenue, Joseph W. Golden, Ph.D. and colleagues at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) first demonstrated that mice without critical viral sensing “machinery” were less sensitive to CCHFV infection. These mice lacked a necessary protein called mitochondrial antiviral signaling protein (MAVS) and the finding occurred even when type I interferon, another key component of the , was also inactivated. This was a surprising finding, according to Golden, who said the mice should have been hypersensitive to infection because they lacked important innate protection systems.

“In fact, in MAVS-deficient mice, the virus failed to induce a potent inflammatory response, and levels of virus even decreased in the liver, a key target tissue for this virus,” he explained. This led USAMRIID investigators to suspect that over-production of inflammatory cytokines, a type of signaling molecule involved in the immune response, could be contributing to .

By studying infection in mice lacking key cytokine pathways, the researchers determined that TNF-α receptor signaling was a significant driver of CCHFV-mediated disease. They were able to protect infected with CCHFV using antibodies targeting TNF-α. Surprisingly, they also determined that while a less virulent strain of CCHFV caused a milder inflammatory response than a lethal strain of the virus, the two strains caused similar levels of liver damage. Importantly, their work demonstrates that help drive CCHFV disease outcomes.

USAMRIID has studied CCHFV for decades, and with the relatively recent development of suitable animal model systems, Golden and his team have focused their research on two areas: understanding how the virus causes disease and developing vaccines and drugs to prevent or treat infection. The group previously identified a critical protein called glycoprotein 38 (GP38) as an important antiviral antibody target. That research paved the way for development of immunotherapies that could be used to protect humans exposed to the virus. They also developed a DNA vaccine capable of protecting against the virus that is currently in pre-clinical development. With this latest study, the USAMRIID team has identified the host inflammatory response as a new target for drug intervention.

Their body of work offers the prospect of a combined therapeutic approach that both targets the virus and modulates the host response to help prevent , according to study co-author Aura Garrison, Ph.D. “With these recent advances, we hope to soon see vaccines and therapeutics being developed for human use to mitigate the threat of CCHFV,” she said.

Scientists develop novel therapy for Crimean-Congo hemorrhagic fever virus

More information:
Joseph W. Golden et al, The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected mice, PLOS Pathogens (2022). DOI: 10.1371/journal.ppat.1010485

Research sheds light on crimean-congo hemorrhagic fever disease process (2022, May 20)
retrieved 20 May 2022

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Original Source Link


Please enter your comment!
Please enter your name here

Latest News

Reducing tech addiction requires collective action

I always had a complicated relationship with technology. I would like it, then realize I like it too...

ZEBEDEE Introduces Instant Global Payments Using The Bitcoin Lightning Network

Along with the ability to earn bitcoin, users will now be able to easily and instantly transfer their...

China grants billions in bailouts as Belt and Road Initiative falters

China has significantly expanded its bailout lending as its Belt and Road Initiative blows up following a series...

Amazon opens Sidewalk to developers, providing SDKs and hardware development kits, and claims over 90% of the US population can now access the public...

Jennifer Pattison Tuohy / The Verge: Amazon opens Sidewalk to developers, providing SDKs and hardware development kits, and...

How ChatGPT tech has been applied to healthcare

There is a lot of hype around AI in healthcare and a rush of digital health companies seeking...

West Virginia Legislature Enacts RFRA, With Abortion Carveout

The West Virginia legislature has enacted a version of the Religious Freedom Restoration Act (RFRA). (H/T Religion Clause)...

Must Read

Taylor Swift : "Midnight Rain" – Live In Las Vegas (The Eras Tour)

My feet were hurting so much from standing...

Chia seedlings verify Alan Turing’s ideas about patterns in nature

LAS VEGAS – Chia seeds sprouted in trays...
- Advertisement -

You might also likeRELATED
Recommended to you